Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Kyorin discusses design of anti-MRSA cephalosporins with affinity for PBP2'

Dec. 6, 1999

Pfizer presents novel hygromycin derivatives with antibacterial/antiprotozoal properties

Dec. 6, 1999

Schering-Plough to manufacture Ampligen for HemispheRx

Dec. 6, 1999

Rhodacyanine dye MKT-077 is a potential candidate antimalarial agent

Dec. 3, 1999

FR-901469 derivatives synthesized and tested as antifungal agents at Fujisawa

Dec. 3, 1999

Resveratrol inhibits HSV replication

Dec. 3, 1999

Results presented at ASTMH demonstrate safety and efficacy of tafenoquine in malaria

Dec. 2, 1999

Bayer's CMV product advances to phase II

Dec. 2, 1999

ASTMH news: PS-22, a new antimalarial prodrug, tested for toxicity

Dec. 2, 1999

Lilly presents modified glycopeptides with antibacterial activity

Dec. 2, 1999

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...